AbbVie
ABBV
#31
Rank
HK$2.362 T
Marketcap
HK$1,337
Share price
-1.26%
Change (1 day)
5.87%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2023 (TTM): HK$28.81

According to AbbVie's latest financial reports the company's current EPS (TTM) is HK$28.66. In 2022 the company made an earnings per share (EPS) of HK$51.83 an increase over its 2021 EPS that were of HK$50.50.

EPS history for AbbVie from 2011 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$28.81-44.42%
2022HK$51.832.63%
2021HK$50.50125.21%
2020HK$22.43-45.69%
2019HK$41.2948.35%
2018HK$27.837.6%
2017HK$25.87-9.3%
2016HK$28.5215.48%
2015HK$24.70185.53%
2014HK$8.65-57.11%
2013HK$20.17-21.69%
2012HK$25.7655.73%
2011HK$16.54

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
HK$14.48-49.47%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$30.91 7.86%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$42.27 47.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$110.16 284.44%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$34.18 19.27%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$143.72 401.54%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$27.25-4.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.45-46.07%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$15.26-46.75%๐Ÿ‡บ๐Ÿ‡ธ USA